Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.

Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ.

J Child Adolesc Psychopharmacol. 2000 Fall;10(3):193-204.

PMID:
11052409
[PubMed - indexed for MEDLINE]
3.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
[PubMed - indexed for MEDLINE]
4.

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.

Swanson JM, Greenhill LL, Lopez FA, Sedillo A, Earl CQ, Jiang JG, Biederman J.

J Clin Psychiatry. 2006 Jan;67(1):137-47.

PMID:
16426100
[PubMed - indexed for MEDLINE]
5.

Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.

Boellner SW, Earl CQ, Arora S.

Curr Med Res Opin. 2006 Dec;22(12):2457-65.

PMID:
17257460
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.

Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.

Pediatrics. 2005 Dec;116(6):e777-84.

PMID:
16322134
[PubMed - indexed for MEDLINE]
Free Article
7.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
[PubMed - indexed for MEDLINE]
8.

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

Spencer T, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, Tarazi R, Faraone SV.

Arch Gen Psychiatry. 2002 Jul;59(7):649-56.

PMID:
12090818
[PubMed - indexed for MEDLINE]
9.

Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.

Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A; LYCY Study Group.

Eur Neuropsychopharmacol. 2009 Nov;19(11):822-34. doi: 10.1016/j.euroneuro.2009.07.008. Epub 2009 Aug 28.

PMID:
19716683
[PubMed - indexed for MEDLINE]
10.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group.

J Clin Psychiatry. 2006 May;67(5):727-35.

PMID:
16841622
[PubMed - indexed for MEDLINE]
12.

A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.

Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, West SA, Sangal RB, Bohan TP, Zeldis JB.

J Child Adolesc Psychopharmacol. 2004 Winter;14(4):542-54.

PMID:
15662146
[PubMed - indexed for MEDLINE]
13.

Nortriptyline in the treatment of ADHD: a chart review of 58 cases.

Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T.

J Am Acad Child Adolesc Psychiatry. 1993 Mar;32(2):343-9.

PMID:
8444763
[PubMed - indexed for MEDLINE]
14.

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.

Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A.

J Clin Psychopharmacol. 1999 Jun;19(3):257-64.

PMID:
10350032
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.

Svanborg P, Thernlund G, Gustafsson PA, Hägglöf B, Poole L, Kadesjö B.

Eur Child Adolesc Psychiatry. 2009 Apr;18(4):240-9. doi: 10.1007/s00787-008-0725-5. Epub 2009 Jan 20.

PMID:
19156355
[PubMed - indexed for MEDLINE]
16.

Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.

Bostic JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, Sienna M, Polisner DA, Hatch M.

J Child Adolesc Psychopharmacol. 2000 Fall;10(3):205-16.

PMID:
11052410
[PubMed - indexed for MEDLINE]
17.

Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.

Amiri S, Mohammadi MR, Mohammadi M, Nouroozinejad GH, Kahbazi M, Akhondzadeh S.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):145-9. Epub 2007 Aug 8.

PMID:
17765380
[PubMed - indexed for MEDLINE]
18.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
[PubMed - indexed for MEDLINE]
19.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
[PubMed - indexed for MEDLINE]
20.

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.

Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK.

J Clin Psychiatry. 2007 Jan;68(1):93-101.

PMID:
17284136
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk